En español
NIDA

NIDA researchers confirm important brain reward pathway

NIH study in rodents identifies a pathway that starts with glutamate and ends with activation of dopamine reward system

November 12, 2014

Details of the role of glutamate, the brain’s excitatory chemical, in a drug reward pathway have been identified for the first time.

This discovery in rodents - published today in Nature Communications - shows that stimulation of glutamate neurons in a specific brain region (the dorsal raphe nucleus) leads to activation of dopamine-containing neurons in the brain’s reward circuit (dopamine reward system).

neurons in ventral tegmental areaPartial view of labelled neurons in reward circuitry that starts in dorsal raphe
(pictured – ventral tegmental area)
Image courtesy Dr. Marisela Morales, NIDA IRP

Dopamine is a neurotransmitter present in regions of the brain that regulate movement, emotion, motivation, and feelings of pleasure. Glutamate is a neurotransmitter whose receptors are important for neural communication, memory formation, and learning. The research was conducted at the Intramural Research Program (IRP) of the National Institute on Drug Abuse (NIDA), which is part of the National Institutes of Health.

The research focused on the dorsal raphe nucleus, which has long been a brain region of interest to drug abuse researchers, since nerve cells in this area connect to part of the dopamine reward system. Many of the pathways are rich in serotonin, a neurotransmitter linked to mood regulation. Even though electrical stimulation of the dorsal raphe nucleus promotes reward-related behaviors, drugs that increase serotonin have low abuse potential. As a result, this region of the brain has always presented a seeming contradiction, since it is involved in drug reward but is also abundant in serotonin - a chemical not known for a role in drug reinforcement. This has led researchers to theorize that another neurotransmitter may be responsible for the role that the dorsal raphe nucleus plays in reward.

“We now have strong evidence of a reward pathway that starts with stimulation of glutamate neurons in the dorsal raphe nucleus and ends in activation of the dopamine reward system,” said NIDA Director Dr. Nora D. Volkow. “These findings help us better understand the brain’s reward circuitry and opens up new avenues of research into the neurobiology of drug addiction.”

In these rodent models, researchers used special tracers and labelling compounds to confirm that this circuit in the reward pathway begins with glutamate cells in the dorsal raphe nucleus that connect to dopamine cells in the ventral tegmental area, which in turn travel to the nucleus accumbens, a brain structure linked to motivation, pleasure, and reward.  After verifying the pathway, investigators used optogenetic techniques (using light to control activity of modified cells) and chemical blockers to confirm that glutamate, not serotonin, is responsible for activating this reward circuitry.

“This glutamatergic pathway is the first fully characterized link between electrically stimulated reward circuitry and the dopamine system on which it depends,” said Dr. Marisela Morales, NIDA IRP scientist and senior author on the paper. “The discovery of this specific brain pathway opens new avenues to examine its participation in a variety of disorders related to motivation.”

The paper by Qi et al. can be found at www.nature.com/ncomms/index.html. For similar research currently being conducted by NIDA IRP in this area, go to: http://irp.drugabuse.gov/cnrb.php#Anchor-Anatomy-48213.

Contact:
NIDA Press Office
301-443-6245
media@nida.nih.gov

About the National Institute on Drug Abuse (NIDA): The National Institute on Drug Abuse (NIDA) is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports most of the world’s research on the health aspects of drug use and addiction. The Institute carries out a large variety of programs to inform policy, improve practice, and advance addiction science. Fact sheets on the health effects of drugs and information on NIDA research and other activities can be found at www.drugabuse.gov, which is now compatible with your smartphone, iPad or tablet. To order publications in English or Spanish, call NIDA’s DrugPubs research dissemination center at 1-877-NIDA-NIH or 240-645-0228 (TDD) or email requests to drugpubs@nida.nih.gov. Online ordering is available at drugpubs.drugabuse.gov. NIDA’s media guide can be found at www.drugabuse.gov/publications/media-guide/dear-journalist, and its easy-to-read website can be found at www.easyread.drugabuse.gov. You can follow NIDA on Twitter and Facebook.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

NIH. . .Turning Discovery Into Health®

News Releases

Nov 2016

Oct 2016

Sep 2016

Aug 2016

Jul 2016

Jun 2016

May 2016

Apr 2016

Mar 2016

Feb 2016

Jan 2016

Dec 2015

Nov 2015

Oct 2015

Sep 2015

Aug 2015

Jul 2015

Jun 2015

May 2015

Apr 2015

Mar 2015

Feb 2015

Jan 2015

Dec 2014

Nov 2014

Oct 2014

Sep 2014

Aug 2014

Jul 2014

Jun 2014

May 2014

Apr 2014

Mar 2014

Feb 2014

Jan 2014

Dec 2013

Nov 2013

Oct 2013

Sep 2013

Aug 2013

Jul 2013

Jun 2013

May 2013

Apr 2013

Mar 2013

Feb 2013

Jan 2013

Dec 2012

Nov 2012

Oct 2012

Sep 2012

Aug 2012

Jul 2012

Jun 2012

May 2012

Apr 2012

Mar 2012

Feb 2012

Jan 2012

Dec 2011

Nov 2011

Oct 2011

Sep 2011

Aug 2011

Jul 2011

Jun 2011

May 2011

Apr 2011

Mar 2011

Jan 2011

Dec 2010

Nov 2010

Sep 2010

Aug 2010

Jul 2010

May 2010

Apr 2010

Mar 2010

Jan 2010

Get this Publication

Cite this article

APA style citation

NIDA (). NIDA researchers confirm important brain reward pathway. Retrieved , from https://www.drugabuse.gov/news-events/news-releases/2014/11/nida-researchers-confirm-important-brain-reward-pathway

press ctrl+c to copy
Receive Latest Science Articles in your Email!
You will only receive messages related to Latest Science